ESOPHAGEAL SCC

Clinical trials for ESOPHAGEAL SCC explained in plain language.

Never miss a new study

Get alerted when new ESOPHAGEAL SCC trials appear

Sign up with your email to follow new studies for ESOPHAGEAL SCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Terminated trial tests new drug cocktails for tough cancers

Disease control Terminated

This early-stage study tested two different drug combinations (TNO155 with either spartalizumab or ribociclib) in adults with advanced solid tumors, including lung, head and neck, and colorectal cancers. The main goal was to find safe doses and understand side effects, not to cur…

Matched conditions: ESOPHAGEAL SCC

Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

ESOPHAGEAL SCC

Get alerted when new ESOPHAGEAL SCC trials appear

Terminated trial tests new drug cocktails for tough cancers